To study the effectiveness and safety of artesunate + sulphadoxine- pyrimethamine in patients with uncomplicated falciparum malaria
Phase 4
Completed
- Conditions
- Health Condition 1: null- uncomplicated falciparum malaria
- Registration Number
- CTRI/2011/091/000047
- Lead Sponsor
- Govt Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. Age > 12 years
2. Slide confirmed cases with only plasmodium falciparum
Exclusion Criteria
1. Presence of danger signs of Plasmodium falciparum (According to WHO Criteria)
2. Past history of hypersensitivity to sulfa drugs
3. History of recent uptake of malaria treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Parasitological clearance on 28th dayTimepoint:
- Secondary Outcome Measures
Name Time Method 1). Fever clearance time (axillary temperature < 37.5oC) <br>2). Parasite Clearance time.<br>Timepoint: